The Valley Desk

NCT04570956 · Interventional trial

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Overall registry status Terminated

Phase 2

Conditions Breast Atypical Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Carcinoma, Breast Lobular Carcinoma in Situ

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov